Clinical importance of the CagA and VacA protiens and of the host factores in the development of peptic ulcer in patients infected by Helicobacter pylori;Relevancia clínica de las proteínas CagA y VacA y de los factores del huésped en el desarrollo de úlcera péptica en pacientes infectados por Helicobacter Pylori

Revista Clinica Espanola

Volumn 203, Issue 9, 2003, Pages 430-433

  Toro Rueda, Carlos ^a   Garcia Samaneigo J ^a   Casado Farinas I ^a   Rubio Alonso, M ^b   Baquero Mochales, M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

Alcohol; CagA; Helicobacter pylori; Peptic ulcer; Tobacco; VacA

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DYSPEPSIA; FEMALE; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HOST PATHOGEN INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PEPTIC ULCER; PROTEIN ANALYSIS; RISK FACTOR; SEX DIFFERENCE; TOBACCO DEPENDENCE; WESTERN BLOTTING;

EID: 0141841608     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13052561     Document Type: Article

References (19)

1. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991;100:1495-501.
2. Sipponen R, Varis K, Fraki O, Korri UM, Seppälä K, Siurala M. Cumulative 10 yr risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. Scand J Gastroenterol 1990;25:966-73.
3. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991; 338:332-5.
4. Aucher P, Petit ML, Mannant PR, Pezennec L, Babin P, Fauchere JL. Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers. J Clin Microbiol 1998;36:931-6.
5. Graham DY, Yamaoka Y. Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter 2000;5 Suppl 1:S3-9.
6. Chen TS, Chang FY, Lee SD. Smoking and male gender rather than CagA protein are associated with increased risk for duodenal ulcer in Helicobacter pylori-infected patients in Taiwan. Dig Dis Sci 1999;44: 2076-80.
7. Figueiredo C, Quint W, Nouhan N, vanden Munckhof H, Herbrink P, Schepernisse J, et al. Assessment of Helicobacter pylori vacA and cagA genotypes and host serological response. J Clin Microbiol 2001;39:1339-44.
8. Atherton JC, Peek RM Jr, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997;112:92-9.
9. Alarcón T, Domingo D, Martínez MJ, López-Brea M. cagA gene and vacA alleles in Spanish Helicobacter pylori clinical isolates from patients of different ages. FEMS Immunol Med Microbiol 1999; 24:215-9.
10. Gisbert JP, Boixeda D, de Argila CM, Bermejo F, Redondo C, de Rafael L. Erosive duodenitis: prevalence of Helicobacter pylori infection and response to eradication therapy with omeprazole plus two antibiotics. Eur J Gastroenterol Hepatol 1997;9:957-62.
11. Lamarque D, Gilbert T, Roudot-Thoraval F, Deforges L, Chaumette MT, Delchier JC. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa. Eur J Gastroenterol Hepatol 1999;11:721-6.
12. Martín Guerrero JM, Hergueta Delgado P, Esteban Carretero J, Romero Castro R, Pellicer Bautista FJ, Herrerías Gutiérrez JM. Relevancia clínica de las cepas de Helicobacter pylori CagA positivo: marcador de lesiones pépticas gastroduodenales. Rev Esp Enferm Dig 2000;92:160-73.
13. Santolaria S, Lanas A, Benito R, Piazuelo E, Sáinz R. Anticuerpos frente a las citotoxinas CagA y VacA y riesgo de úlcera péptica en pacientes con infección por Helicobacter pylori. Med Clin (Barc) 2001; 116:641-4.
14. Valmaseda T, Gisbert JP, Paniagua M, Pajares JM. Anticuerpos frente a la citotoxina CagA de Helicobacter pylori en diversas enfermedades gastroduodenales en dos poblaciones diferentes. Med Clin (Barc) 2002; 118:90-3.
15. Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, et al. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 1998; 42:338-43.
16. Hua J, Zheng PY, Yeoh KG, Ho B. The status of the cagA gene does not predict Helicobacter pylori-associated peptic ulcer disease in Singapore. Microbios 2000;102:113-20.
17. Ando T, Peek RM Jr, Lee YC, Krishna U, Kusugami K, Blaser MJ. Host cell responses to genotypically similar Helicobacter pylori isolates from United States and Japan. Clin Diagn Lab Immunol 2002;9:167-75.
18. Lorente S, Doiz O, Trinidad Serrano M, Castillo J, Lanas A. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Gut 2002;50:13-8.
19. Kekki M, Samloff IM, Ihamaki T, Varis K, Siurala M. Age- and sex-related behaviour of gastric acid secretion at the population level. Scand J Gastroenterol 1982;17:737-43.